title: Ion transport and regulation of respiratory tract fluid output in dogs.
abstract: To investigate the regulation of respiratory tract fluid output (RTFO), we collected the RTFO in an anesthetized canine model after a series of pharmacological interventions (inhibition of Na(+)-K(+)-ATPase or Na(+)-K(+)-2Cl(-) cotransporter, 250 microl) and physiological challenges (ionic and/or osmotic perturbation in airway lumen, 250 microl). Whereas 250 microl of aerosolized 0.9% saline caused a transient increase in RTFO, a 250-microl bumetanide-induced increase in RTFO was evident for 18 min and a 250-microl acetylstrophanthidin-induced increase in RTFO persisted for at least 30 min. Dry air ventilation decreased the responses of RTFO to the saline (sham) and acetylstrophanthidin intervention but not the bumetanide intervention. Delivery of 250 mosmol/kgH(2)O ion-free mannitol (250 microl) caused marked increases in RTFO that were little affected by the administration of acetylstrophanthidin or bumetanide 30 min before these challenges. A 250-microl 550 mosmol/kgH(2)O ion-free mannitol challenge caused a more marked and prolonged increase in RTFO. Thus aerosol delivery of a low dose of a cardiac glycoside or a near-isosmotic, ion-free, impermeant osmolyte solution may be therapeutically useful by increasing the clearance of secretions from the tracheobronchial airways.
authors.affiliation: Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
authors.forename: B T
authors.initials: BT
authors.lastname: Chen
authors.forename: D B
authors.initials: DB
authors.lastname: Yeates
mesh_terms: D000818:Animals; D001826:Body Fluids / Q000187:drug effects / Q000502:physiology*; D002034:Bumetanide / Q000494:pharmacology; D002245:Carbon Dioxide / Q000097:blood; D002352:Carrier Proteins / Q000037:antagonists & inhibitors; D002712:Chlorides / Q000378:metabolism; D004285:Dogs; D006706:Homeostasis; D006813:Humidity; D007700:Kinetics; D008297:Male; D008353:Mannitol / Q000493:pharmacokinetics; D010100:Oxygen / Q000097:blood; D011188:Potassium / Q000378:metabolism; D012143:Respiratory Physiological Phenomena / Q000187:drug effects; D012964:Sodium / Q000378:metabolism; D028021:Sodium-Potassium-Chloride Symporters; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors; D013327:Strophanthidin / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D002352:Carrier Proteins; D002712:Chlorides; D028021:Sodium-Potassium-Chloride Symporters; D002034:Bumetanide; D002245:Carbon Dioxide; D008353:Mannitol; D013327:Strophanthidin; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; C004681:acetylstrophanthidin; D011188:Potassium; D010100:Oxygen